An analysis of patient data from Fenway Health in Boston shows that PrEP is an effective form of prevention against HIV infection. The analysis was presented in an abstract at the HIV Research for Prevention meeting in Madrid on Tuesday, …
Fenway Health is conducting a new study on gender-affirmative health care starting this November. This innovative study, titled “Transgender cohort study of gender affirmation and HIV-related health,” will enroll 4,500 transgender adult patients from Fenway Health and Callen-Lorde Community Health …
September 18 marks National HIV/AIDS and Aging Awareness Day, a time to examine the challenges faced by older adults around HIV prevention, testing, treatment, and care. Seniors may be less aware of prevention best practices and HIV exposure risks, …
Study Examines Efficacy of Interventions for Young Transgender Women in Reducing HIV Infection Risks
BOSTON, August 13, 2018—A new HIV prevention study published today in JAMA Pediatrics found that Project Lifeskills—a culturally specific, empowerment-based, and group-delivered behavioral prevention intervention—significantly reduced sexual risk for HIV acquisition and transmission in sexually active young transgender women …
First study to identify an association between PrEP use and receipt of primary care, with potential benefits beyond HIV prevention
Users of HIV pre-exposure prophylaxis (PrEP), a daily pill to prevent HIV infection, are more likely to use non-HIV-related primary …
Understanding syndemics. Developing strategies to overcome barriers to care for transgender people. Expanding access to PrEP. Using digital technologies to stop HIV.
These are some of the areas that scientists and researchers at The Fenway Institute are exploring to fight …
Currently, no vaccine exists that can cure HIV, the virus that causes AIDS. Today, 36.7 million people are living with HIV/AIDS. Despite progress with antiretroviral therapy and other research dedicated to stopping this disease, there still is a dire need …
India, home to over 1.3 billion people, is experiencing the third largest HIV epidemic in the world. According to UNAIDS, there are 2.1 million people currently living with HIV/AIDS in the country, with only half of those people accessing antiretroviral …
The BNAB (Broadly Neutralizing Antibody) study, also known as HPTN 087/HVTN 127, explores the tolerability and the impact that an experimental antibody has on the human immune system. The antibody being explored in this study is the VCRCO7-523LS antibody. According …
The BNAB (Broadly Neutralizing Antibody) study, also known as HPTN 087/HVTN 127, explores the tolerability and the impact that an experimental antibody has on the human immune system. The antibody being explored in this study is the VCRCO7-523LS antibody. According …